Overview
Linear IgA dermatosis (LAD) is a rare subepidermal autoimmune bullous disease characterized by predominant immunoglobulin A deposits at the basement membrane zone, affecting both children and adults 1.Diagnosis
Clinical Features: Vesicles and bullae, often with mucosal involvement 1.
Histopathology: Subepidermal blister formation with IgA deposition at the basement membrane zone on direct immunofluorescence 1.
Direct Immunofluorescence: Essential for confirming IgA deposition 1.
Indirect Immunofluorescence: Useful for detecting circulating IgA autoantibodies 1.
Biopsy: Required for histopathological confirmation 1.
Differential Diagnosis: Includes bullous pemphigoid, dermatitis herpetiformis, and other subepidermal blistering disorders 1.Management
First-Line Treatments:
- Corticosteroids: Topical or systemic, depending on disease severity 1.
- Dapsone: Effective for many patients, especially those with mild to moderate disease 1.
Adjunctive Treatments:
- Immunosuppressants: Azathioprine, mycophenolate mofetil, or ciclosporin for refractory cases 1.
- Biologics: TNF-α inhibitors or rituximab considered in severe, refractory cases 1.Special Populations
Pediatrics: Similar management principles apply, with careful monitoring of growth and development 1.
Pregnancy: Management requires careful consideration of teratogenic risks; corticosteroids and dapsone are often used cautiously 1.
Elderly: Increased vigilance for side effects of systemic treatments; topical therapy may be preferred initially 1.
Comorbidities: Tailor treatment considering potential drug interactions and organ function 1.Key Recommendations
Diagnosis should include histopathology and direct immunofluorescence to confirm IgA deposition at the basement membrane zone (Evidence: Expert opinion 1).
Topical or systemic corticosteroids are recommended as first-line therapy for LAD (Evidence: Expert opinion 1).
Dapsone should be considered for patients with mild to moderate LAD (Evidence: Expert opinion 1).
Refractory cases may require immunosuppressive agents such as azathioprine or ciclosporin (Evidence: Expert opinion 1).
Management in pregnant patients should prioritize safety, often starting with corticosteroids or dapsone (Evidence: Expert opinion 1).
Close monitoring is essential in elderly patients due to increased risk of side effects from systemic treatments (Evidence: Expert opinion 1).References
1 Caux F, Patsatsi A, Karakioulaki M, Antiga E, Baselga E, Borradori L et al.. S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology and Venereology : JEADV 2024. link